 |
 |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
|
|
Novera is a Louisville, Kentucky life science company, pioneering the direct delivery of energy (ATP) to cells for wound healing applications. The Company's mission is to revolutionize wound healing with state-of-the-art biotechnology while providing shareholders a high return on investment. Part of Novera's strategy toward accomplishing these objectives is to align itself with relevant experts to quicken the development process and improve its chances of success. Moreover, Novera has structured these relationships such that they greatly reduce the operating cost associated with new drug development. Continuing with its commitment to quick and efficient product development, Novera will focus on orphan drug designations for both acute and chronic wound treatments and rely on out-licensing for much of the late-stage responsibilities such as marketing and distribution. The progress is guided by experienced leadership representing both the business and science fields.© 2007 Novera Pharmaceuticals. All rights reserved.
A VitaTech Company
201 East Jefferson Street, Suite 104, Louisville, KY 40202
p 502.569.1030 — f 502.569.1029
info@noveradrugs.com
VitaTech is a registered trademark of VitaTech Engineering
Web site developed by Cytenance